23 May 2013
Keywords: enrollment, begins, phase, ii, rhb1, trials, somatogen
Article | 21 November 1994
Somatogen has begun enrolling patients into two Phase II trials of its
recombinant hemoglobin product, rHb1.1, which is intended for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 November 1994
14 November 1994
22 May 2013
© 2013 thepharmaletter.com